ALN-HTT02

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-HTT02, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease [Phase 1]